Luye Pharma Group Ltd. (02186) released its Monthly Return on Movements in Securities for January 2026. As of January 31, 2026, the company’s authorized share capital remained at 10,000,000,000 ordinary shares with a par value of USD 0.02 each, totaling USD 200,000,000. No changes were recorded in the number of issued ordinary shares or treasury shares, with the issued total staying at 3,994,515,953 shares.

In addition, the company noted an outstanding USD 180,000,000 in convertible bonds (stock code: 05818), carrying a conversion price of HKD 4.88. These bonds could potentially convert into 288,793,032 ordinary shares, though no new shares were issued under these convertibles during the month. The company confirmed compliance with the relevant public float requirement as of the period-end.